Immunome (IMNM) Return on Equity [ROE] (2021 - 2026)
Immunome (IMNM) reported Return on Equity [ROE] of -48.57% for Q2 2026, up 29.37 percentage points from -77.93% a year earlier but down 9.52 percentage points from the prior quarter.
Powered by 
Analysis
Immunome (IMNM) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Immunome posted Return on Equity [ROE] of -54.96%, up 148.19 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +374.12 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -203.16% in FY2024 (-42.72 pp), -160.44% in FY2023 (-46.62 pp), -113.83% in FY2022 (-57.52 pp) and -56.30% in FY2021 (+372.78 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -294.07% in Q3 2023 and a high of -37.14% in Q3 2021.
- Year over year, Return on Equity [ROE] has now increased in each of the last 11 quarters, with an average year-over-year change of +57.55 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2024 (a gain of 158.61 percentage points); the low point was Q3 2023 (a drop of 155.55 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -39.05% (Q1 2026), -49.90% (Q4 2025) and -87.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Immunome | 2.44 Bn | 410.39 Mn | - | -48.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.57% |
| Mar 31, 2026 | -39.05% |
| Dec 31, 2025 | -49.90% |
| Sep 30, 2025 | -87.86% |
| Jun 30, 2025 | -77.93% |
| Mar 31, 2025 | -89.35% |
| Dec 31, 2024 | -154.42% |
| Sep 30, 2024 | -135.46% |
| Jun 30, 2024 | -100.70% |
| Mar 31, 2024 | -117.08% |
| Dec 31, 2023 | -173.92% |
| Sep 30, 2023 | -294.07% |
| Jun 30, 2023 | -229.01% |
| Mar 31, 2023 | -194.78% |
| Dec 31, 2022 | -185.73% |
| Sep 30, 2022 | -138.52% |
| Jun 30, 2022 | -106.08% |
| Mar 31, 2022 | -76.60% |
| Dec 31, 2021 | -48.95% |
| Sep 30, 2021 | -37.14% |
API Access
Immunome Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();